Michael D Tarantino MD
Clotting Disorder, Hematologic Oncology, Hemophilia & Bleeding Disorder
Medical Director and President, The Bleeding and Clotting Disorders Institute
Join to View Full Profile
427 W Northmoor RdPeoria, IL 61614
Phone+1 309-692-5337
Fax+1 309-693-3913
Dr. Tarantino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Tarantino is a hematologist in Peoria, IL and is affiliated with multiple hospitals in the area, including UnityPoint Health - Peoria, OSF Saint Francis Medical Center, and UnityPoint Health - Proctor. He received his medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice 30 years. He specializes in clotting disorder, hematologic oncology, and hemophilia & bleeding disorder and is experienced in amyloidosis, hematologic oncology, platelet disorders, myelodysplasia, and myelofibrosis.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Pediatric Hematology/Oncology, 1990 - 1993
University of Arizona College of Medicine-TucsonResidency, Pediatrics, 1987 - 1990
University of Wisconsin School of Medicine & Public HealthClass of 1987
Certifications & Licensure
AZ State Medical License 1990 - Present
IL State Medical License 1999 - 2026
KY State Medical License 1993 - 2026
WI State Medical License 1990 - 2001
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Physician of the Year National Hemophilia Foundation, 2012
Clinical Trials
- Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901 Start of enrollment: 2001 Nov 22
- Survey of Inhibitors in Plasma-Product Exposed Toddlers Start of enrollment: 2010 Jan 01
- A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) Start of enrollment: 2014 Jul 14
- Join now to see all
Publications & Presentations
PubMed
- Safety, efficacy, and treatment satisfaction in adults with ITP who switched to avatrombopag from another TPO-RA.Michael D Tarantino, Kailash Mosalpuria, Scott Kolodny, Jie Jessica Zhang, Michael Vredenburg
Blood Advances. 2025-03-18 - Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study.Nichola Cooper, A J Gerard Jansen, Robert Bird, Jiří Mayer, Michelle Sholzberg
American Journal of Hematology. 2025-03-01 - Clinical efficacy of simoctocog alfa versus extended half-life recombinant FVIII concentrates in hemophilia A patients undergoing personalized prophylaxis using a matc...Craig M Kessler, Fernando F Corrales-Medina, Pier Mannuccio Mannucci, Víctor Jiménez-Yuste, Michael D Tarantino
European Journal of Haematology. 2023-11-01
Journal Articles
- An Outbreak of Synthetic Cannabinoid–Associated Coagulopathy in IllinoisAnnia Martial, Michael D Tarantino, Jonathan C Roberts, Amar H Kelkar, Harsha Moole, The New England Journal of Medicine
Abstracts/Posters
- Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) PatientsMichael D. Tarantino, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary OutcomeMichael D. Tarantino, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Clinical Careers in Hematology (Private Practice Careers)61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Career-Development Lunch Sessions: Clinical Careers in Hematology (Private Practice)60th American Society of Hematology Annual Meeting - 12/1/2018
- Immune Thrombocytopenia in US Clinical Practice: Incidence and Healthcare Utilization/Expenditures in the First 12 Months Following Diagnosis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Outbreak of Synthetic Cannabinoid–Associated Bleeding Disorders in IllinoisSeptember 27th, 2018
FDA Approves Nplate® (Romiplostim) for Use in Pediatric Patients with Immune ThrombocytopeniaJuly 15th, 2008
Professional Memberships
- Member
- Fellow
- American Society of Pediatric Hematology/OncologyMember
- Society for Pediatric ResearchMember
- International Society for Thrombosis and HemostasisMember
- National Hemophilia FoundationMember
- Platelet Disorders Support AssociationMember
- Peoria Medical SocietyMember
- State Medical Society of IllinoisMember
- Medical and Scientific Advisory Council of the National Hemophilia FoundationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
